Renowned Sinus Surgeon Dr. Peter-John Wormald Comments on AmpliPhi Biosciences' Favorable Phase 1 Results of AB-SA01 in Chronic Rhinosinusitis Patients
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.